<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2653
  </number>
  <updateDate>
   2023-01-11T13:48:42Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:42Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-19
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 67 (Monday, April 19, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Miss GONZALEZ-COLON:H.R. 2653.Congress has the power to enact this legislation pursuantto the following:The Congress shall have Power To lay and collect Taxes,Duties, Imposts and Excises, to pay the Debts and provide forthe common Defence and general welfare of the United States;but all Duties, Imposts and Excises shall be uniformthroughout the United States; [. . .]--And To make all lawswhich shall be necessary and proper for carrying intoExecution the foregoing Powers, and all other Powers vestedby this Constitution in the Government of the United States,or in any Department or Officer thereof.[Page H1955]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-20T16:45:44Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-19T16:03:05Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-19T16:03:00Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     MMEDS Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     1203
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-04-19
     </actionDate>
     <text>
      Read twice and referred to the Committee on Finance.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-04-20
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-19
    </actionDate>
    <text>
     Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-19
    </actionDate>
    <text>
     Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-19
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-19
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     G000582
    </bioguideId>
    <fullName>
     Resident Commissioner González-Colón, Jenniffer [R-PR-At Large]
    </fullName>
    <firstName>
     Jenniffer
    </firstName>
    <lastName>
     Gonzalez-Colon
    </lastName>
    <party>
     R
    </party>
    <state>
     PR
    </state>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     S000168
    </bioguideId>
    <fullName>
     Rep. Salazar, Maria Elvira [R-FL-27]
    </fullName>
    <firstName>
     Maria
    </firstName>
    <lastName>
     Salazar
    </lastName>
    <party>
     R
    </party>
    <state>
     FL
    </state>
    <middleName>
     Elvira
    </middleName>
    <district>
     27
    </district>
    <sponsorshipDate>
     2021-04-19
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001200
    </bioguideId>
    <fullName>
     Rep. Soto, Darren [D-FL-9]
    </fullName>
    <firstName>
     Darren
    </firstName>
    <lastName>
     Soto
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-04-19
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000600
    </bioguideId>
    <fullName>
     Rep. Diaz-Balart, Mario [R-FL-25]
    </fullName>
    <firstName>
     Mario
    </firstName>
    <lastName>
     Diaz-Balart
    </lastName>
    <party>
     R
    </party>
    <state>
     FL
    </state>
    <district>
     25
    </district>
    <sponsorshipDate>
     2021-04-19
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000574
    </bioguideId>
    <fullName>
     Rep. Gallego, Ruben [D-AZ-7]
    </fullName>
    <firstName>
     Ruben
    </firstName>
    <lastName>
     Gallego
    </lastName>
    <party>
     D
    </party>
    <state>
     AZ
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-04-19
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Taxation
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Aging
     </name>
    </item>
    <item>
     <name>
      Business expenses
     </name>
    </item>
    <item>
     <name>
      Business investment and capital
     </name>
    </item>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Community life and organization
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Economic development
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Housing and community development funding
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Income tax credits
     </name>
    </item>
    <item>
     <name>
      Income tax deductions
     </name>
    </item>
    <item>
     <name>
      Industrial facilities
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Medical research
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Minority and disadvantaged businesses
     </name>
    </item>
    <item>
     <name>
      Minority health
     </name>
    </item>
    <item>
     <name>
      Poverty and welfare assistance
     </name>
    </item>
    <item>
     <name>
      Public-private cooperation
     </name>
    </item>
    <item>
     <name>
      Research administration and funding
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
    <item>
     <name>
      Strategic materials and reserves
     </name>
    </item>
    <item>
     <name>
      Unemployment
     </name>
    </item>
    <item>
     <name>
      Veterans' medical care
     </name>
    </item>
    <item>
     <name>
      Wages and earnings
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Taxation
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-19
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-07-08T16:01:39Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Medical Manufacturing, Economic Development, and Sustainability Act of 2021 or the MMEDS Act of 2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical manufacturers. The bill increases the credit rate for minority businesses.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   MMEDS Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     MMEDS Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To rescue domestic medical manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     MMEDS Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Medical Manufacturing, Economic Development, and Sustainability Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-19T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2653ih/xml/BILLS-117hr2653ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-20
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-20
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-19
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-19
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-19
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-19
9
Library of Congress
Introduced in House
IntroReferral
2021-04-19T16:03:05Z
Referred to
House
Energy and Commerce Committee
2021-04-20T16:45:44Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-04-19T16:03:00Z
Referred to
House
Ways and Means Committee
hswm00
Standing
S000168
27
Maria
Rep. Salazar, Maria Elvira [R-FL-27]
Salazar
Elvira
R
2021-04-19
FL
S001200
9
Darren
Rep. Soto, Darren [D-FL-9]
Soto
D
2021-04-19
FL
D000600
25
Mario
Rep. Diaz-Balart, Mario [R-FL-25]
Diaz-Balart
R
2021-04-19
FL
G000574
7
Ruben
Rep. Gallego, Ruben [D-AZ-7]
Gallego
D
2021-04-19
AZ
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-19
2021-04-20
Referred to the Subcommittee on Health.
House
Taxation
2021-04-19
Read twice and referred to the Committee on Finance.
CRS
Related bill
MMEDS Act of 2021
S
G000582
Jenniffer
Resident Commissioner González-Colón, Jenniffer [R-PR-At Large]
N
Gonzalez-Colon
R
PR
Aging Business expenses Business investment and capital Cardiovascular and respiratory health Community life and organization Congressional oversight Drug safety, medical device, and laboratory regulation Economic development Emergency medical services and trauma care Government studies and investigations Health technology, devices, supplies Housing and community development funding Immunology and vaccination Income tax credits Income tax deductions Industrial facilities Infectious and parasitic diseases Manufacturing Medical research Medical tests and diagnostic methods Minority and disadvantaged businesses Minority health Poverty and welfare assistance Public-private cooperation Research administration and funding Research and development Strategic materials and reserves Unemployment Veterans' medical care Wages and earnings
2021-04-19
Introduced in House
 <p><b>Medical Manufacturing, Economic Development, and Sustainability Act of 2021 or the MMEDS Act of 2021</b></p> <p>This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical manufacturers. The bill increases the credit rate for minority businesses.</p>
2021-07-08T16:01:39Z
00
2021-04-19T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2653ih/xml/BILLS-117hr2653ih.xml
MMEDS Act of 2021
MMEDS Act of 2021
Display Title
IH
Introduced in House
To rescue domestic medical manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.
Official Title as Introduced
IH
Introduced in House
MMEDS Act of 2021
Short Title(s) as Introduced
IH
Introduced in House
Medical Manufacturing, Economic Development, and Sustainability Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:48:42Z
2023-01-11T13:48:42Z
3.0.0
2021-04-19
Read twice and referred to the Committee on Finance.
CRS
Related bill
MMEDS Act of 2021
S
2021-04-20
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-19
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-19
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-19
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-19
9
Library of Congress
Introduced in House
IntroReferral
G000582
Jenniffer
Resident Commissioner González-Colón, Jenniffer [R-PR-At Large]
N
Gonzalez-Colon
R
PR
S000168
27
Maria
Rep. Salazar, Maria Elvira [R-FL-27]
Salazar
Elvira
R
2021-04-19
FL
S001200
9
Darren
Rep. Soto, Darren [D-FL-9]
Soto
D
2021-04-19
FL
D000600
25
Mario
Rep. Diaz-Balart, Mario [R-FL-25]
Diaz-Balart
R
2021-04-19
FL
G000574
7
Ruben
Rep. Gallego, Ruben [D-AZ-7]
Gallego
D
2021-04-19
AZ
Aging Business expenses Business investment and capital Cardiovascular and respiratory health Community life and organization Congressional oversight Drug safety, medical device, and laboratory regulation Economic development Emergency medical services and trauma care Government studies and investigations Health technology, devices, supplies Housing and community development funding Immunology and vaccination Income tax credits Income tax deductions Industrial facilities Infectious and parasitic diseases Manufacturing Medical research Medical tests and diagnostic methods Minority and disadvantaged businesses Minority health Poverty and welfare assistance Public-private cooperation Research administration and funding Research and development Strategic materials and reserves Unemployment Veterans' medical care Wages and earnings
2021-04-19
Introduced in House
 <p><b>Medical Manufacturing, Economic Development, and Sustainability Act of 2021 or the MMEDS Act of 2021</b></p> <p>This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical manufacturers. The bill increases the credit rate for minority businesses.</p>
2021-07-08T16:01:39Z
00
MMEDS Act of 2021
MMEDS Act of 2021
Display Title
IH
Introduced in House
To rescue domestic medical manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.
Official Title as Introduced
IH
Introduced in House
MMEDS Act of 2021
Short Title(s) as Introduced
IH
Introduced in House
Medical Manufacturing, Economic Development, and Sustainability Act of 2021
Short Title(s) as Introduced
2021-04-20
Referred to the Subcommittee on Health.